Aurinia Pharmaceuticals
AUPH
#4863
Rank
A$2.69 B
Marketcap
A$20.41
Share price
0.63%
Change (1 day)
64.47%
Change (1 year)

Market capitalization of Aurinia Pharmaceuticals (AUPH)

Market cap: A$2.69 Billion

As of February 2026 Aurinia Pharmaceuticals has a market cap of A$2.69 Billion. This makes Aurinia Pharmaceuticals the world's 4863th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aurinia Pharmaceuticals from 2009 to 2026

End of year Market Cap

Year Marketcap Change
2026A$2.69 B-15.86%
2025A$3.19 B51.04%
2024A$2.11 B11.76%
2023A$1.89 B110.05%
2022A$0.90 B-77.95%
2021A$4.09 B80.46%
2020A$2.26 B-29.47%
2019A$3.21 B288.64%
2018A$0.82 B68.75%
2017A$0.49 B323.6%
2016A$0.11 B4.08%
2015A$0.11 B-20.03%
2014A$0.13 B172.12%
2013A$51.07 M397.78%
2012A$10.26 M-48.54%
2011A$19.93 M-50.08%
2010A$39.93 M73.38%
2009A$23.03 M

End of Day market cap according to different sources

On Feb 19th, 2026 the market cap of Aurinia Pharmaceuticals was reported to be:

A$2.69 Billion
by Nasdaq info icon info icon
A$2.69 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
A$117.24 B 4,256.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
A$25.45 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
A$24.82 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA